Driving the future of medicines manufacturing
From digital chemistry to advanced CMC solutions, we turn cutting-edge science into real-world impact.
CMAC combines world-class research with industry collaboration to deliver practical, scalable solutions in advanced manufacturing, which includes digital chemistry, manufacturing and controls (CMC). Our strength lies in a multi-disciplinary ecosystem that integrates expertise in research, technology development and professional services, ensuring end-to-end innovation.
At the heart of this ecosystem is our CMC DataFactory®. Our specialist streams, such as CCS, MCS+, BPCS and QbDD, enable rapid translation of science into industrial-scale processes.
Our Translation to Industry portfolio offers multiple engagement pathways, including staff exchanges, placements, expert-led training and pre-competitive programmes to foster co-creation and accelerate technology adoption.
With a proven track record of partnerships with global pharma, CDMOs, and innovation centres, CMAC is shaping the UK’s innovation landscape.
Our Strategic Collaborators
We work with global industrial partners to co-create and translate world-leading research into impactful, industry-ready technologies across the Technology Readiness Levels.
Through this partnership model, we accelerate the digitalisation of CMC processes, enabling the adoption of advanced pharmaceutical manufacturing solutions.
Our partnerships go beyond our industry membership, offering many routes to collaboration. We actively work with academic institutions, regulatory bodies, government agencies and other industry organisations to drive innovation and shape the future of medicines.
If you’d like to work with CMAC, reach out to our team for a discussion about how we can support your goals.
-
Together with our Tier One global pharma partners, we are delivering our strategy through a portfolio of collaborative, precompetitive research, translation and skills projects, driving innovation and impact across the medicines manufacturing landscape.
-
We collaborate with leading CDMOs and tech vendors to accelerate CMC innovation, combining expertise in crystallisation, PAT, and digitisation with CMAC’s facilities to deliver integrated, efficient solutions for advanced medicines manufacturing.
-
Our Tier Two community is a dynamic network spanning digital technologies, data analytics, advanced manufacturing, consultancy, and specialised CROs, each bringing unique expertise to support shared goals through formal collaboration.
-
Our academic partners are leading universities and research institutions that work with us to advance cutting-edge research, whilst sharing expertise and developing solutions that shape the future of medicines.
-
CMAC works closely with industry, government, regulators and the third-sector to align research, policy, and practice to accelerate innovation, ensure regulatory confidence and deliver impact across the full value chain.
Translation to Industry
Our Translation to Industry portfolio demonstrates our commitment to turning academic research into practical, scalable solutions for pharmaceutical manufacturing. We work with companies across the Technology Readiness Level (TRL) spectrum, bridging the gap between theory and real-world application to deliver measurable impact for our partners.
Through our portfolio, companies have access to opportunities, including:
TRL-based development and progression, including commercialisation via our CMC DataFactories® and National Facility
Staff exchanges i.e. secondments for knowledge exchange and PhD placements to build future talent
Tailored 1:1 project partnerships and pre-competitive, industry-funded programmes to drive innovation and shared success
OpenCMC - your gateway to commercialisation and TRL scale-up
CMAC SkillsFactory in-person and online training for workforce development
Other Engagement Routes
-
CMAC National Facility
CMAC’s national facility supports companies to accelerate innovation through flexible, fee-for-use access to our labs, technologies and specialist expertise. Leveraging integrated services and strong industry partnerships, we deliver streamlined, end-to-end solutions that support a smooth transition from concept to commercialisation.
-
Collaborative Opportunities
We partner with organisations on funding awards, Knowledge Transfer Partnerships and strategic initiatives that drive innovation and impact.
-
PhD@Work
Advance your career and earn a PhD through CMAC’s PhD@Work programme, where flexible study meets real-world impact.
“CMAC has a unique way of working that’s been really successful. They listen to what the industry needs and align with industrial strategies. It very much feels like a partnership.”
— Jon-Paul Sherlock, AstraZeneca
